site stats

Thomas stankovich

WebPreparing Thomas's profile… View Thomas's Email (It's Free) 5 free lookups per month. No credit card required. Location. Boston, Massachusetts, United States. Education. … WebOct 19, 2024 · Thomas Stankovich Chief Financial Officer 949-276-6042 [email protected]. Investor Contact: Daniel Kontoh-Boateng Assistant Vice …

Thomas Stankovich - Biografie

WebAug 24, 2024 · RSLS: STANKOVICH THOMAS: Chief Financial Officer: Jan 31: Sale: 1.22: 3,684: 4,494: 358,852: Feb 02 04:22 PM: RSLS: STANKOVICH THOMAS: Chief Financial Officer: Jan 04 ... WebRumbold, Alice R., Tan, Sarah E., Stankovich, Jim, Garland, Suzanne M., Condon, John R., Taylor-Thomson, Debbie, Nickels, Maria, Tabrizi, Sepehr N., Davy, Margaret L ... mn made utility trailers https://lindabucci.net

A Golden Celebration: As July 4th approaches, Thomas …

WebICN Pharmaceuticals. 1986 - 200014 years. Responsible for $400M region. Direct reports: 8. Developed Central and Eastern European region. Integrated 7 OEMs, 3 distributors and … WebGuruFocus Article or News written by hollywood1450 and the topic is about: WebOct 30, 2024 · "I am very excited to be joining the ReShape team," commented Thomas Stankovich, Chief Financial Officer of ReShape Lifesciences. "This is a pivotal time for the … mnm agency

Thomas Stankovich, Chief Financial Officer, ReShape Lifesciences

Category:Thomas Stankovich Net Worth, Biography, and Insider …

Tags:Thomas stankovich

Thomas stankovich

ReShape Lifesciences to Present at Dawson James 6th Annual

WebThomas Stankovich - ETRM / EnteroMedics Inc - Insider Trade Report. Fintel ... WebFeb 28, 2024 · Name Role Date Shares Price Value; Thomas Stankovich: Chief Financial Officer: 2024-02-28: 103: $4.25

Thomas stankovich

Did you know?

WebOct 30, 2024 · Mr. Stankovich has over 25 years of executive leadership experience as the CFO for multiple public and private healthcare companies. Tom has spent the past nine … WebThomas Stankovich Net Worth 2024 and insider trades. Provides CEO, CFO, Director and Chief Executives trade reports, independent equity research, and stock screening. Get …

WebOct 30, 2024 · On October 30, 2024, ReShape Lifesciences Inc. announced the appointment of Thomas Stankovich as the Company's Chief Financial Officer effective immediately. …

WebExhibit 99.1 . ReShape Lifesciences Appoints Thomas Stankovich as Chief Financial Officer . SAN CLEMENTE, CA, October 30, 2024 - ReShape Lifesciences Inc. (OTCQB: RSLS), a … WebOct 30, 2024 · Mr. Stankovich has over 25 years of executive leadership experience as the CFO for multiple public and private healthcare companies. Tom has spent the past nine years as the Global Senior Vice ...

WebSAN CLEMENTE, CA / ACCESSWIRE / October 30, 2024 / ReShape Lifesciences Inc. (OTCQB:RSLS), a leading developer and distributor of minimally invasive medical devices …

WebExplore {Cobalis's key management people. Discover current leadership team members including founders, CEO, other executives and board directors. initiator\\u0027s x9WebTom Stankovich Thomas Stankovich Senior Vice President and CFO, M P Biomedicals Inc. Add Current Location. Find other people named Tom Stankovich. General Info. Add … initiator\\u0027s xbWebJul 2, 2005 · Recently, Thomas Stankovich, a Yugoslav, was publicly acknowledged for his social and economic endeavors. Among those who have previously been honored are the … mn ma health insuranceWebApr 12, 2024 · STANKOVICH THOMAS, the Chief Financial Officer of ReShape Lifesciences Inc., sale 157 shares at $13.29 during a trade that took place back on Feb 02, which … mn ma hearing aidsWebFeb 28, 2024 · What is Thomas Stankovich's net worth? The estimated net worth of Thomas Stankovich is at least $1.56 million as of November 4th, 2024. Mr. Stankovich owns … initiator\u0027s xeWebTom Stankovich is Chief Financial Officer at Reshape Lifesciences Inc. See Tom Stankovich's compensation, career history, education, & memberships. initiator\\u0027s xaWebAug 24, 2024 · Options Flow - Real Time Feed; Put/Call Ratio - Top Bullish; Put Call Ratio - Top Bearish; SEC mn managed care ombudsman